Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.
H Cuppens, … , B Nilius, J J Cassiman
H Cuppens, … , B Nilius, J J Cassiman
Published January 15, 1998
Citation Information: J Clin Invest. 1998;101(2):487-496. https://doi.org/10.1172/JCI639.
View: Text | PDF
Research Article Article has an altmetric score of 19

Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.

  • Text
  • PDF
Abstract

In congenital bilateral absence of the vas deferens patients, the T5 allele at the polymorphic Tn locus in the CFTR (cystic fibrosis transmembrane conductance regulator) gene is a frequent disease mutation with incomplete penetrance. This T5 allele will result in a high proportion of CFTR transcripts that lack exon 9, whose translation products will not contribute to apical chloride channel activity. Besides the polymorphic Tn locus, more than 120 polymorphisms have been described in the CFTR gene. We hypothesized that the combination of particular alleles at several polymorphic loci might result in less functional or even insufficient CFTR protein. Analysis of three polymorphic loci with frequent alleles in the general population showed that, in addition to the known effect of the Tn locus, the quantity and quality of CFTR transcripts and/or proteins was affected by two other polymorphic loci: (TG)m and M470V. On a T7 background, the (TG)11 allele gave a 2.8-fold increase in the proportion of CFTR transcripts that lacked exon 9, and (TG)12 gave a sixfold increase, compared with the (TG)10 allele. T5 CFTR genes derived from patients were found to carry a high number of TG repeats, while T5 CFTR genes derived from healthy CF fathers harbored a low number of TG repeats. Moreover, it was found that M470 CFTR proteins matured more slowly, and that they had a 1.7-fold increased intrinsic chloride channel activity compared with V470 CFTR proteins, suggesting that the M470V locus might also play a role in the partial penetrance of T5 as a disease mutation. Such polyvariant mutant genes could explain why apparently normal CFTR genes cause disease. Moreover, they might be responsible for variation in the phenotypic expression of CFTR mutations, and be of relevance in other genetic diseases.

Authors

H Cuppens, W Lin, M Jaspers, B Costes, H Teng, A Vankeerberghen, M Jorissen, G Droogmans, I Reynaert, M Goossens, B Nilius, J J Cassiman

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 Total
Citations: 1 5 6 3 6 13 5 7 10 12 6 8 11 10 29 14 14 14 21 17 27 22 7 13 10 10 11 3 315
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2013 (11)

Title and authors Publication Year
The silent codon change I507-ATC->ATT contributes to the severity of the  F508 CFTR channel dysfunction
A Lazrak, L Fu, V Bali, R Bartoszewski, A Rab, V Havasi, S Keiles, J Kappes, R Kumar, E Lefkowitz, EJ Sorscher, S Matalon, JF Collawn, Z Bebok
The FASEB Journal 2013
Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease
DN Cooper, M Krawczak, C Polychronakos, C Tyler-Smith, H Kehrer-Sawatzki
Human Genetics 2013
Analysis of CFTR Gene Variants in Idiopathic Bronchiectasis in Serbian Children
K Milosevic, A Nikolic, AD Rankov, M Ljujic, B Nestorovic, D Radojkovic
Pediatric Allergy, Immunology, and Pulmonology 2013
CFTR haplotypes in northern Iranian population
VK Oskooei, MR Dooki, R Tabaripour, S Mirzajani, R Pourbagher, H Akhavan-Niaki
Gene 2013
Association of CFTR gene variants with nontuberculous mycobacterial lung disease in a Korean population with a low prevalence of cystic fibrosis
MA Jang, SY Kim, BH Jeong, HY Park, K Jeon, JW Kim, CS Ki, WJ Koh
Journal of Human Genetics 2013
TDP-43 high throughput screening analyses in neurodegeneration: Advantages and pitfalls
E Buratti, M Romano, FE Baralle
Molecular and Cellular Neuroscience 2013
Emery and Rimoin's Principles and Practice of Medical Genetics
DC Wallace, MT Lott, V Procaccio
Emery and Rimoin's Principles and Practice of Medical Genetics 2013
Fine Characterization of the Recurrent c.1584+18672A>G Deep-Intronic Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Gene
L Costantino, D Rusconi, G Soldà, M Seia, V Paracchini, L Porcaro, R Asselta, C Colombo, S Duga
American journal of respiratory cell and molecular biology 2013
New insights into the genetic basis of TAR (thrombocytopenia-absent radii) syndrome
CA Albers, R Newbury-Ecob, WH Ouwehand, C Ghevaert
Current Opinion in Genetics & Development 2013
Molecular Testing for Cystic Fibrosis Carrier Status Practice Guidelines: Recommendations of the National Society of Genetic Counselors
E Langfelder-Schwind, B Karczeski, MN Strecker, J Redman, EA Sugarman, C Zaleski, T Brown, S Keiles, A Powers, S Ghate, R Darrah
Journal of Genetic Counseling 2013
Dinucleotide Circular Codes
CJ Michel, G Pirillo
ISRN Biomathematics 2013

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 policy sources
Referenced in 1 patents
On 1 Facebook pages
Referenced in 3 clinical guideline sources
94 readers on Mendeley
See more details